Abstract:One of the major disappointments in human autoimmunity has been the relative failure on genome-wide association studies to provide “smoking genetic guns” that would explain the critical role of genetic susceptibility to loss of tolerance. It is well known that autoimmunity refers to the abnormal state that the dysregulated immune system attacks the healthy cells and tissues due to the loss of immunological tolerance to self-antigens. Its clinical outcomes are generally characterized by the presence of autoreactive immune cells and (or) the development of autoantibodies, leading to various types of autoimmune disorders. The etiology and pathogenesis of autoimmune diseases are highly complex. Both genetic predisposition and environmental factors such as nutrition, infection, and chemicals are implicated in the pathogenic process of autoimmunity, however, how much and by what mechanisms each of these factors contribute to the development of autoimmunity remain unclear. Epigenetics, which refers to potentially heritable changes in gene expression and function that do not involve alterations of the DNA sequence, has provided us with a brand new key to answer these questions. In the recent decades, increasing evidence have demonstrated the roles of epigenetic dysregulation, including DNA methylation, histone modification, and noncoding RNA, in the pathogenesis of autoimmune diseases, especially systemic lupus erythematosus (SLE), which have shed light on a new era for autoimmunity research. Notably, DNA hypomethylation and reactivation of the inactive X chromosome are two epigenetic hallmarks of SLE. We will herein discuss briefly how genetic studies fail to completely elucidate the pathogenesis of autoimmune diseases and present a comprehensive review on landmark epigenetic findings in autoimmune diseases, taking SLE as an extensively studied example. The epigenetics of other autoimmune diseases such as rheumatic arthritis, systemic sclerosis and primary biliary cirrhosis will also be summarized. Importantly we emphasize that the stochastic processes that lead to DNA modification may be the lynch pins that drive the initial break in tolerance.

The Role of Sirtuin-1 in Immune Response and Systemic Lupus Erythematosus

Dysregulated T Cell Activation and Aberrant Cytokine Expression Profile in Systemic Lupus Erythematosus.

Immunological pathogenesis and treatment of systemic lupus erythematosus

Long Non-Coding RNAs in Systemic Lupus Erythematosus: New Insights into Disease Pathogenesis and Diagnosis.

Post-translational Modifications in T Cells in Systemic Erythematosus Lupus

Research Progress of Sirt1 in Immune Regulation

Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target

Lipid Metabolism: Immune Regulation and Therapeutic Prospectives in Systemic Lupus Erythematosus

Association of Signaling Transducers and Activators of Transcription 1 and Systemic Lupus Erythematosus

SIRT1 slows the progression of lupus nephritis by regulating the NLRP3 inflammasome through ROS/TRPM2/Ca2+ channel

Unveiling the Nexus: Decoding Interactions Between Regulated Cell Death and Systemic Lupus Erythematosus Pathogenesis for Innovative Therapeutic Avenues

Role of Interleukin-10 and Interleukin-10 Receptor in Systemic Lupus Erythematosus

Regulation of Sirt1 on energy metabolism and immune response in rheumatoid arthritis

The critical role of epigenetics in systemic lupus erythematosus and autoimmunity

Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus

Roles of IL ‐1 and IL ‐10 family cytokines in the progression of systemic lupus erythematosus: Friends or foes?

The role of deacetylase SIRT1 in allergic diseases

The Role of Autophagy in the Pathogenesis of Systemic Lupus Erythematosus

Mtor Signaling: A Pivotal Player in Treg Cell Dysfunction in Systemic Lupus Erythematosus.

SIRT1: A Potential Therapeutic Target in Autoimmune Diseases

Intercellular interplay between Sirt1 signalling and cell metabolism in immune cell biology